STONKWHISPER
← Back to Intel
Insider ActivityCTNM

Lorrain Daniel S., Chief Scientific Officer at Contineum Therapeutics, Inc., sold $51K of CTNM

Updated Jun 15, 2026
Lorrain Daniel S. Chief Scientific Officer
Contineum Therapeutics, Inc. · $CTNM
$51K Total Value
3,870 Shares Traded
$13.06 Price / Share
143,842 Shares Owned After
2026-05-01 Filing Date

Transaction Details

InsiderLorrain Daniel S.
TitleChief Scientific Officer
CompanyContineum Therapeutics, Inc.
TickerCTNM
Transaction TypeSale
Transaction Date2026-05-01
Shares Traded3,870
Price Per Share$13.06
Total Value$51K
Filed Date2026-05-01
Accession Number0001628280-26-029435

Ownership Context

Shares Owned After Transaction143,842
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001628280-26-029435

Other Insider Trades — CTNM

Other Trades by Lorrain Daniel S.

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for CTNM — Contineum Therapeutics, Inc. →

Track CTNM insider activity in real time on The Wire →

Get alerts when Lorrain Daniel S. files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 15, 2026 at 07:14 UTC

Want real-time data? Access The Wire for live sentiment tracking.